Drug Trial Radar · NCT02207699
Evaluation of the Effect of Benzonatate on QT Intervals Following Single Dose Administration of Benzonatate to Healthy Volunteers
Last checked: Nov 20, 2026Latest source record: Aug 4, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
68
Actual
Start
May 2014
Primary completion
Jul 2014
Study completion Jul 2014
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 4, 2014
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Basic science
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study is to determine the effects of benzonatate (200 mg and 800 mg) on the QT interval following single dose oral administration at each time point post-dose.
Conditions
- Healthy Volunteers
Interventions
Benzonatate 200 mgDrug
2 benzonatate 100 mg perles and 6 placebo perles give by mouth once
Benzonatate 800 mgDrug
8 benzonatate 100 mg perles given by mouth once
Moxifloxacin 400 mgDrug
1 moxifloxacin 400 mg tablet given by mouth once
PlaceboDrug
8 placebo perles given by mouth once
Primary outcomes
What the sponsor says the trial is designed to measure.
- Fridericia-corrected QTc change from the pre-dose time point to the post-dose time points following administration of study drug in therapeutic (200 mg) and supratherapeutic doses (800 mg).Time frame: -1, -0.75, -0.5, 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 6, 12, and 24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Pfizer Investigational Site
Overland Park, Kansas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.